Hemogenyx Pharmaceuticals Share Discussion Threads

[lean5gb] 13/12/2024 12:14

Im in at 250p.... I have the patience, but,...... It'll not be a long wait .. :0)))

[johnpope] 13/12/2024 09:21

This is done for No one will buy

[luckyabbeygale] 13/12/2024 08:17

Now equivalent to 0.9p.

[luckyabbeygale] 11/12/2024 11:18

JackNife's pockets are endless and his shorts are hammering the price and the company will be forced to do a 0.5p placing.Without JackNife this would of never gone to 1p and the placing would of been at a premium and my bet would of never been stopped out and now I be showing a huge profit. JackNife is what keeps the spread bet company's happy.

[luckyabbeygale] 11/12/2024 09:14

You can see how JackNife shorts always wins since he keeps on increasing huge shorting trades to force the price down.

[luckyabbeygale] 10/12/2024 15:32

It makes sense how I get such a buzz out of trolling JackNife in every way I can. One thing people hate to see is someone having such success and I feel the same and especially when it is out of the misery of shorting peoples dreams.

[luckyabbeygale] 10/12/2024 15:02

Looks like 0.5p at Hemo in the short term. I wonder what JackNife profits margin will look like then.

[luckyabbeygale] 10/12/2024 12:33

I hope your profits from shorting Hemo are covering your losses over in FAB. I know in general they hate you with a vengeance over on the FAB thread.

[bones698] 09/12/2024 13:33

Doesn't look good from most aspects . Placing possible will kill the ap . Chart looks awful. Lack of positive news and slow developments ..not one to be invested in currently me thinks

[luckyabbeygale] 09/12/2024 08:03

Jack Knife 1.9m short from Friday is looking even better.

[pangrati] 09/12/2024 07:45

Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented:

"This step marks a significant milestone for the Company as we advance our lead asset, HG-CT-1, into clinical trials. This study represents our commitment to developing innovative therapies for patients with R/R AML, a condition with limited treatment options.

We are excited to see patient recruitment set to begin and take the next steps in assessing the safety and treatment potential of HEMO-CAR-T. We remain dedicated to delivering transformative therapies that address critical unmet medical needs."

[pangrati] 09/12/2024 07:40

Site Initiation Visit Completed

Hemogenyx Pharmaceuticals Successfully Completes the Site Initiation Visit of the First Clinical Site for Phase I Clinical Trial of HG-CT-1

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical company developing innovative therapies for blood diseases, is pleased to announce the successful completion of the Site Initiation Visit at the first clinical site for its Phase I clinical trial of HG-CT-1 (also known as HEMO-CAR-T). The Phase I clinical trial is designed as a dose escalation study to assess the safety of HG-CT-1 in adult patients with relapsed/refractory (R/R) acute myeloid leukaemia (AML).

Patient recruitment will begin once the clinical site provides final details to the Company's clinical trials manager, Prevail Infoworks.

[lean5gb] 06/12/2024 08:42

Yep. Placing on its way.. "Once sufficient resources are available to CBR, we are confident in our ability to translate these scientific breakthroughs into impactful treatments."

[luckyabbeygale] 06/12/2024 08:31

Jack Knife has opened up a 1.9m short. I be very worried if I was still holding this.

[luckyabbeygale] 06/12/2024 08:30

Sell while you still can.

[luckyabbeygale] 06/12/2024 08:22

Placing at 0.5p has been leaked by the looks of it. Glad I lost half my money in this trash and has put me in 5 grand debt to replace more than the 4k loss.

[ashleyjv] 06/12/2024 07:17

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical-stage biopharmaceutical company, is pleased to announce a breakthrough in its development of a novel method for delivering Chimeric Bait Receptors ("CBR") to innate immune cells such as macrophages and monocytes i.e. the white myeloid blood cells that make up the body's first line of defence against infections and responsible for the removal of diseased or damaged cells. This innovative approach utilizes lentiviral vectors (a laboratory constructed and modified retrovirus that can be used to insert genetic material into cells) to achieve highly efficient transduction of macrophages or monocytes, while maintaining durable, long-lasting CBR expression in these cells. In more simple terms, the new methodology will extend the efficacy as well as the durability of CBR within transduced cells.

The Company believes that this innovative approach to myeloid immune cell transduction will significantly accelerate the development of CBR-based product candidates, facilitating their progression into IND-enabling studies.



The Company's first-class scientific team continues to make good progress with CBR and, once sufficient resources are provided, the Company anticipates moving new CBR-based product candidates into clinical trials, bringing them closer to addressing unmet medical needs.



Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "We are thrilled to announce this critical advancement in our CBR platform, which represents a significant step forward in our mission to develop cutting-edge therapies for unmet medical needs. Overcoming the challenges of efficiently delivering CBRs to myeloid immune cells has been a key focus for our team, and this breakthrough underscores their dedication and ingenuity We remain committed to leveraging this technology to bring transformative therapies to the clinic and, ultimately, to patients in need. Once sufficient resources are available to CBR, we are confident in our ability to translate these scientific breakthroughs into impactful treatments."

[master rsi] 28/11/2024 12:11

Bid gone to 1.102p

Stop talking to yourself Jacky ( two in one )

re - never wrong

only wrong the day before yesterday
yesterday
today
tomorrow
and the day after

[luckyabbeygale] 28/11/2024 11:55

A surprise placing at 0.5p is expected. Remember that Jack Knife is never wrong and I would of saved myself four grand last week if I had of listened to him. Now I have had to take out an emergency 5k loan.

[master rsi] 28/11/2024 11:39

and now 1.20p offer
and small buys pay the full 1.20p

[atmysignal] 28/11/2024 10:59

Bouncy bouncy